Infant Maternal Vaccine by Pfizer Receives FDA Approval

The Food and Drug Administration (FDA) has granted approval for a new vaccine developed by Pfizer to protect infants from respiratory syncytial virus (RSV), which is the leading cause of hospitalization among babies in the U.S. Pfizer’s RSV shot is already available for older adults. This vaccine is the second treatment approved by the FDA …

Read more

Top 10 drugs potentially subjected to autumnal Medicare price negotiations

Merck & Co. Inc.’s Januvia brand medication, used to treat Type 2 diabetes. Daniel Acker | Bloomberg | Getty Images Medicare is set to enter direct negotiations with the pharmaceutical industry this fall to determine drug prices, marking the first time in the program’s history. The Centers for Medicare and Medicaid Services (CMS) will soon …

Read more

CDC advisors back Infant RSV shot, clearing path for fall availability

A child infected with RSV undergoes treatment at Missio children’s clinic Moenchberg in Wuerzburg, Germany, on December 2, 2022. Heiko Becker | Reuters An advisory panel to the Centers for Disease Control and Prevention unanimously endorsed the first shot that offers protection against respiratory syncytial virus (RSV) for infants. RSV is the leading cause of …

Read more

Premarket Buzz: INTC, ROKU, PG Stocks in the Spotlight

Intel shares rose by 6.7% following the release of their better-than-expected second-quarter results, marking a return to profitability after two consecutive losing periods. The company’s third-quarter forecast also surpassed analyst predictions. Intel reported adjusted earnings of 13 cents a share on revenues of $12.95 billion. Roku’s stock rallied nearly 10% after reporting a narrower-than-expected loss …

Read more

Infant RSV Shot Anticipated by Sanofi Ahead of Fall Virus Season

A doctor is administering a vaccine to a baby boy. Karl Tapales | Moment | Getty Images Sanofi anticipates the release of its infant RSV shot in the United States before the respiratory virus season this fall, according to a company spokesperson. The Food and Drug Administration granted approval on Monday for Beyfortus, a monoclonal …

Read more

FDA grants approval for AstraZeneca and Sanofi’s RSV vaccine for infants and toddlers

Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images The Food and Drug Administration (FDA) has granted approval on Monday for AstraZeneca and Sanofi’s breakthrough shot that provides protection against respiratory syncytial virus (RSV) in infants and toddlers. RSV is the primary cause of hospitalization among babies in the U.S. …

Read more

Moderna Enters Partnership to Advance mRNA Drug Development in China

Nikos Pekiaridis | Nurphoto | Getty Images Moderna announced a groundbreaking collaboration with Chinese officials to conduct research, development, and manufacturing of messenger RNA medicines within China. This deal comes at a time of escalating tensions between the United States and China, demonstrating Moderna’s commitment to global partnerships and innovation in the field of biotech. …

Read more

Rivian, UPS, Coinbase, and Others: The Latest Updates

SAN ANSELMO, CALIFORNIA – JUNE 06: In this photo illustration, the Coinbase logo is displayed on a screen on June 06, 2023 in San Anselmo, California. The Securities And Exchange Commission has filed a lawsuit against cryptocurrency exchange Coinbase for allegedly violating securities laws by acting as an exchange, a broker and a clearing agency …

Read more